Beyond Type 1 Announces Launch in Five New Languages to Better Serve the Global Diabetes Community

SAN CARLOS, Calif., Feb. 13, 2020 /PRNewswire/ — Beyond Type 1, a global diabetes nonprofit, announced today the launch of websites in Dutch, French, German, Italian, and Swedish. The multi-language expansion serving the Type 1 diabetes community is made possible with support from partners Dexcom and Insulet.

In addition to translating relevant resources from Beyond Type 1’s existing library, the new sites house a growing collection of unique content for the distinct communities they serve. This includes both personal stories and resources for people living with Type 1 diabetes, created for and by the community. Today’s announcement represents the organization’s latest step in serving the global diabetes community with web platforms available in multiple languages. Beyond Type 1 launched in 2015 in English, then launched Beyond Type 1 en Español in 2017.

Mariana Gomez, Senior Manager of Emerging Markets at Beyond Type 1, said, “As we’ve experienced firsthand from our work building Beyond Type 1 en Español, language is far too often a barrier that keeps individuals from accessing resources and connecting with a community that can make a difference in their life with diabetes. We know that we’re already connecting with audiences throughout Europe and the world, and are excited to expand on these efforts by making our content available in new languages.”

The launch of Dutch, French, German, Italian, and Swedish websites represents the next step in  Beyond Type 1’s efforts to better serve the global diabetes community.

Beyond Type 1 CEO Thom Scher said, “We’re thrilled to bring the magic of Beyond Type 1 to so many new people around the world with today’s launch. Beyond Type 1 looks forward to supporting the diabetes community in Europe, partnering with organizations and advocates already doing important work, and building on our efforts in coming months and years. We’re very excited about the direction this new step takes us as an organization.”

DJ Cass, Group VP of International, Insulet commented, “We are delighted to partner with Beyond Type 1 to support greater accessibility to their impressive resource library and localized content across multiple countries in Europe. Beyond Type 1 is doing incredible work to connect and support the global community of people living with diabetes and Insulet is very proud to share their mission to enable many more to benefit from the inspirational peer support and resources offered by their platforms.”

“The world we live in is becoming increasingly borderless, and the diabetes community is no exception,” said Erik Bjorkman, Dexcom General Manager and Vice President for EMEA. “We have numerous patients and work with various healthcare practitioners in the Netherlands, France, Germany, Italy and Sweden, and access to information is critical. We are thrilled to see Beyond Type 1 expand their reach to better support the diabetes community across Europe.”

Beyond Type 1 is also adding an International Committee to its Leadership Council, a group of volunteers who act in an advisory capacity to the Board of Directors and staff. The International Committee will work to identify partners, advocates and opportunities for future growth outside of the United States.

Read this announcement and explore Beyond Type 1 in: Dutch, French, German, Italian, and Swedish.

Media Contact
Todd Boudreaux – Director of Content, Beyond Type 1
editor@beyondtype1.org

 

View original content:http://www.prnewswire.com/news-releases/beyond-type-1-announces-launch-in-five-new-languages-to-better-serve-the-global-diabetes-community-301004446.html

SOURCE Beyond Type 1

Staff

Recent Posts

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

41 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

3 hours ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

3 hours ago